CALC

CalciMedica, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$1.22

Price (1 Year)

$33.7 $1.04

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %26.5 / %30
Non-compliant assets / Total market cap %53.3 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.

Website

Analysis (Turkish): CALC Hissesi Caiz mi, Helal mi? CalciMedica, Inc. Katılım Analizi